Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
2026
Earnings, Q3 FY2026
YTD earnings strengthened; the JPY 190bn FY target remains, despite Q4 cost headwinds.
Earnings, Q2 FY2026
R&D investments target high-margin growth in dermacosmetics and semiconductors, leveraging unique technologies.
Status update
AI-driven marketing tools and agile global teams are accelerating growth and efficiency worldwide.
Earnings, Q1 FY2026
Q1 delivered strong profit growth and margin gains, with full-year outlook unchanged.
2025
Earnings, Q4 FY2025
Strong FY25 results and FY26 growth outlook, with focus on innovation and global expansion.
Earnings, Q3 FY2025
Strong profit growth and margin expansion driven by recovery in cosmetics and cost controls.
Status update
Targets JPY 400B sales and 15% margin by 2027 via global brand focus and operational efficiency.
Earnings, Q2 FY2025
Upward forecast revision reflects robust earnings, market share gains, and strategic reforms.
Earnings, Q1 FY2025
Sales and profits rose sharply, led by cosmetics and UV Care, with guidance unchanged.
2024
Earnings, Q4 FY2024
Profit and margin growth exceeded targets, with 2025 set for further gains and global expansion.
Earnings, Q3 FY2024
Profit and margin growth accelerated by reforms and premium products, despite China cosmetics drag.
Earnings, Q2 FY2024
Status update
Earnings, Q1 FY2024
2023
Earnings, Q4 FY2023
Earnings, Q3 FY2023
Status update
Earnings, Q2 FY2023
Strategy update
Earnings, Q1 FY2023
2022
Earnings, Q4 FY2022
Earnings, Q3 FY2022
Earnings, Q2 FY2022
Earnings, Q1 FY2022